Scan indication | Number of patients | Age distribution* | |||||
---|---|---|---|---|---|---|---|
Total | Male | Female | Total | Male | Female | ||
Cancer of unknown primary origin | Non-DM | 6 | 1 | 5 | 54.5 [35–65] | 53 | 54.8 [35–65] |
DM | 2 | 1 | 1 | 67 [59–75] | 75 | 59 | |
Gastro-intestinal cancer | Non-DM | 3 | 2 | 1 | 57.3 [45–68] | 63.5 [59–68] | 45 |
DM | 1 | 0 | 1 | 57 | – | 57 | |
Head and neck cancer | Non-DM | 15 | 7 | 8 | 58.6 [23–81] | 54.7 [23–81] | 62 [49–72] |
DM | 6 | 2 | 4 | 66.6 [55–77] | 73.5 [70–77] | 63.3 [55–70] | |
Infection and inflammation | Non-DM | 22 | 13 | 9 | 50.4 [22–76] | 49.1 [22–71] | 52.2 [24–76] |
DM | 5 | 3 | 2 | 60.6 [51–74] | 59.3 [52–64] | 62.5 [51–74] | |
Lung cancer | Non-DM | 38 | 18 | 20 | 64.8 [49–81] | 66 [49–78] | 63.7 [51–81] |
DM | 7 | 6 | 1 | 73.4 [69–77] | 74.2 [72–77] | 69 | |
Lymphoma | Non-DM | 16 | 9 | 7 | 55.5 [18–85] | 53.6 [18–85] | 58 [37–72] |
DM | 3 | 3 | 0 | 51.7 [28–64] | 51.7 [28–64] | – | |
Uro-genital cancer | Non-DM | 0 | 0 | 0 | – | – | – |
DM | 2 | 1 | 1 | 69 [63–75] | 75 | 63 | |
Total | Non-DM | 100 | 50 | 50 | 58.4 [18–85] | 57.4 [18–85] | 59.3 [24–81] |
DM | 26 | 16 | 10 | 65.4 [28–77] | 67.2 [28–77] | 62.6 [51–74] |